Search Results 291-300 of 14777 for anti-TNF drugs

  1. Theophylline And Guaifenesin (Oral Route) Before Using - Mayo Clinic

    Adalimumab; Adenosine; Amifampridine; Bupropion ... drugs may be the best treatment for you. If both ... Certain medicines should not be used at or ...

  2. Tailored Antiplatelet Therapy Following PCI - Mayo Clinic

    Clopidogrel is an anti-platelet medication approved by the U.S. Federal Drug Administration (FDA) for use in patients who undergo Percutaneous Coronary ...

  3. Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

    Demonstrated intolerance or inadequate response to one or more anti-tumor necrosis factor (TNF) therapies. Exclusion Criteria: Current diagnosis of ...

  4. Rubella And Mumps Virus Vaccine Live (Intramuscular Route) Before Using - Mayo Clinic

    Adalimumab; Anifrolumab-fnia; Ansuvimab-zykl ... Etanercept; Etrasimod; Everolimus; Fidanacogene ... drugs may be the best treatment for you. If both ...

  5. Tocilizumab-Aazg (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Tocilizumab-aazg injection is used alone or together with other medicines to treat moderate to severe active rheumatoid arthritis in patients who have been ...

  6. Measles - Diagnosis & treatment - Mayo Clinic

    Medications. Treatment for a measles infection may include: Fever reducers. If a fever is making you or your child uncomfortable, you can use ...

  7. Tetanus Toxoid (Intramuscular Route, Injection Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. TE Anatoxal Berna. Canadian Brand Name.

  8. Neuromyelitis optica: New therapies offer hope - Mayo Clinic

    The Food and Drug Administration (FDA) has approved the use of three medications for the treatment of neuromyelitis optica spectrum disorder (NMOSD).

  9. A Study to Identify a Panel of Biomarkers to Predict Response to Anti PD-1 Therapy - Mayo Clinic

    The purpose of this study is to identify a panel of possible biomarkers to predict response to anti PD-1 therapy by establishing the progression free survival ...

  10. Risperidone (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...